Journal of Shanghai Jiao Tong University (Medical Science) >

2023 , Vol. 43 >Issue 8: 988 - 996

DOI: https://doi.org/10.3969/j.issn.1674-8115.2023.08.006

Basic research

Translocator protein activates autophagy in diabetic neuropathic pain rats via regulation of the Keap1/Nrf2/HO-1 signaling

  • Nan GAO ,
  • Gem HAO ,
  • Bingjie MA ,
  • Tian JIN ,
  • Ke MA ,
  • Xiaoming LIU
Expand
  • Department of Pain Management, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200082, China
LIU Xiaoming, E-mail: brightlxm@qq.com.

Received date: 2023-02-14

  Accepted date: 2023-05-25

  Online published: 2023-08-28

Supported by

National Natural Science Foundation of China(81771184)

Fold

Abstract

Objective ·To study the effects of translocator protein (TSPO) agonist Ro5-4864 on autophagy and Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid-derived-2-like 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling in diabetic neuropathic pain (DNP) rats. Methods ·Type 2 diabetic rats were established by high-fat diet and streptozotocin (STZ), and DNP rats were filtered by behavioral assessment. Twenty-four rats were randomly assigned to the Sham group, DNP group, TSPO agonist Ro5-4864 group (Ro group), and TSPO agonist Ro5-4864 combined with Nrf2 inhibitor ML385 group (Ro+ML385 group). Up-Down method was used to measure paw 50% mechanical withdrawal threshold (50% PMWT) of the rats before high-fat diet (baseline), and on Day 3, 7, 14, 21 and 28 after STZ. Sciatic nerves were collected on the last day to analyze the effects of Ro5-4864 on autophagy related proteins and Keap1/Nrf2/HO-1 signaling related proteins of DNP rats by using immunofluorescence and Western blotting. Results ·The 50% PMWT in the DNP group decreased from D3 to D28 (P=0.000 at all timing), and the expression of Bcl-2 interacting coiled-coil protein 1 (Beclin-1), microtubule-associated protein light chain 3-Ⅱ (LC3-Ⅱ), HO-1, and nuclear Nrf2 (P=0.000) were significantly reduced in the sciatic nerves of DNP rats (all P=0.000), compared with those in the sham group, but p62 was significantly increased (P=0.000). Administration of Ro5-4864 attenuated these changes in the rats of the Ro group. There was a gradual increase in the 50% PMWT, compared with that of the rats in the DNP group (D14 P=0.039, both D21 and D28 P=0.000), and the impairment of autophagy and the Keap1/Nrf2/HO-1 signaling was repaired, which was demonstrated by increases of Beclin-1, LC3-Ⅱ, HO-1, and nuclear Nrf2 protein contents (all P=0.000) and a decrease in p62 content (P=0.001). However, the beneficial effects of Ro5-4864 were totally abrogated by ML385 in rats of the Ro+ML385 group. Conclusion ·TSPO alleviates DNP in rats, of which the mechanism involves activation of autophagy via upregulation of the Keap1/Nrf2/HO-1 signaling in sciatic nerves. This study provides a new strategy for the treatment of DNP.

Key words： translocator protein (TSPO); neuropathic pain (NP); diabetes; autophagy; Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid-derived-2-like 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling (Keap1/Nrf2/HO-1 signaling)

Cite this article

Nan GAO , Gem HAO , Bingjie MA , Tian JIN , Ke MA , Xiaoming LIU . Translocator protein activates autophagy in diabetic neuropathic pain rats via regulation of the Keap1/Nrf2/HO-1 signaling[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(8) : 988 -996 . DOI: 10.3969/j.issn.1674-8115.2023.08.006

References

1 RHEE E J, KIM J H, MOON S J, et al. Encountering COVID-19 as endocrinologists[J]. Endocrinol Metab (Seoul), 2020, 35(2): 197-205.
2 FELDMAN E L, CALLAGHAN B C, POP-BUSUI R, et al. Diabetic neuropathy[J]. Nat Rev Dis Primers, 2019, 5: 41.
3 GALLUZZI L, GREEN D R. Autophagy-independent functions of the autophagy machinery[J]. Cell, 2019, 177(7): 1682-1699.
4 MARTANO M, ALTAMURA G, POWER K, et al. Beclin 1, LC3 and P62 expression in equine sarcoids[J]. Animals, 2021, 12(1): 20.
5 CAO W Y, LI J H, YANG K P, et al. An overview of autophagy: mechanism, regulation and research progress[J]. Bull Cancer, 2021, 108(3): 304-322.
6 KLIONSKY D J, PETRONI G, AMARAVADI R K, et al. Autophagy in major human diseases[J]. EMBO J, 2021, 40(19): e108863.
7 CHUNG Y C, LIM J H, OH H M, et al. Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy[J]. Cell Death Dis, 2018, 9(12): 1163.
8 YU C, XIAO J H. The Keap1-Nrf2 system: a mediator between oxidative stress and aging[J]. Oxid Med Cell Longev, 2021, 2021: 6635460.
9 BAIRD L, YAMAMOTO M. The molecular mechanisms regulating the KEAP1-NRF2 pathway[J]. Mol Cell Biol, 2020, 40(13): e00099-e00020.
10 LI S, YANG C, FANG X, et al. Role of Keap1-Nrf2 signaling in anhedonia symptoms in a rat model of chronic neuropathic pain: improvement with sulforaphane[J]. Front Pharmacol, 2018, 9: 887.
11 FRIAS D P, GOMES R L N, YOSHIZAKI K, et al. Nrf2 positively regulates autophagy antioxidant response in human bronchial epithelial cells exposed to diesel exhaust particles[J]. Sci Rep, 2020, 10(1): 3704.
12 RYTER S W. Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation[J]. Arch Biochem Biophys, 2019, 678: 108186.
13 RUPPRECHT R, WETZEL C H, DOROSTKAR M, et al. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?[J]. Mol Psychiatry, 2022, 27(7): 2918-2926.
14 HAO C, MA B J, GAO N, et al. Translocator protein (TSPO) alleviates neuropathic pain by activating spinal autophagy and nuclear SIRT1/PGC-1α signaling in a rat L5 SNL model[J]. J Pain Res, 2022, 15: 767-778.
15 RASHID K, VERHOYEN M, TAIWO M, et al. Translocator protein (18 kDa) (TSPO) ligands activate Nrf2 signaling and attenuate inflammatory responses and oxidative stress in human retinal pigment epithelial cells[J]. Biochem Biophys Res Commun, 2020, 528(2): 261-268.
16 GHEIBI S, KASHFI K, GHASEMI A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin[J]. Biomedecine Pharmacother, 2017, 95: 605-613.
17 CHAPLAN S R, BACH F W, POGREL J W, et al. Quantitative assessment of tactile allodynia in the rat paw[J]. J Neurosci Methods, 1994, 53(1): 55-63.
18 BARRESI E, ROBELLO M, COSTA B, et al. An update into the medicinal chemistry of translocator protein (TSPO) ligands[J]. Eur J Med Chem, 2021, 209: 112924.
19 LIU X M, LIU H J, XU S S, et al. Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model[J]. Pain, 2016, 157(1): 103-116.
20 BLOMS-FUNKE P, SCHUMACHER M, LIU S, et al. A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration[J]. Eur J Pharmacol, 2022, 923: 174935.
21 MARINELLI S, NAZIO F, TINARI A, et al. Schwann cell autophagy counteracts the onset and chronification of neuropathic pain[J]. Pain, 2014, 155(1): 93-107.
22 ARRURI V, KOMIRISHETTY P, ARETI A, et al. Nrf2 and NF-κB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain[J]. Pharmacol Rep, 2017, 69(4): 625-632.
23 DI W, SHI X L, LV H, et al. Activation of the nuclear factor E2-related factor 2/anitioxidant response element alleviates the nitroglycerin-induced hyperalgesia in rats[J]. J Headache Pain, 2016, 17(1): 99.
Options
Outlines

/

〈 〉